Berta Strulovici, Ph.D., is a seasoned leader in the life sciences sector with extensive experience building and mentoring innovative teams across academia and industry. As the Founding Director of the Israel National Center for Personalized Medicine at the Weizmann Institute of Science from 2012 to 2018, Berta developed a collaborative entity focused on personalized medicine. Currently, Berta serves as a Board Member for both Wildtype and Opna Bio, providing strategic leadership and scientific guidance. In addition to holding senior roles at major organizations like Merck & Co., Inc. and Tularik, Inc., Berta has also contributed as a postdoctoral fellow at Duke University Medical Center, specializing in adrenergic receptor signaling.
This person is not in the org chart
This person is not in any teams
This person is not in any offices